Forian Inc. demonstrated consistent progress in Q3 2025, with significant revenue growth and improved profitability driven by strategic investments and core relationship expansion.
Revenue increased 66% to $7.8 million from $4.7 million in the prior year.
positiveAdjusted EBITDA grew 153% to $0.5 million from $0.2 million in the prior year.
positiveNet loss improved by 26% to $0.2 million from $0.2 million in the prior year, with net loss per share remaining flat at $0.00.
neutralMeaningful growth achieved across health economics and outcomes research (HEOR) with new integrations and client renewals.
positiveAdvanced partnerships in Health Services & Delivery to broaden real-world data coverage.
positiveIntroduced new data-driven financial analytics offerings and secured key contracts.
positiveDespite revenue growth, the company still reported a net loss of $0.2 million for the quarter.
attentionCost of revenue increased significantly by 167% YoY, outpacing revenue growth.
attentionSales and marketing expenses increased by 53% YoY, and R&D expenses increased by 132% YoY.
attentionMargin metrics will be available once backend extracts data from insights_json
Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
Consistent progress and execution demonstrated in the third quarter.
Focus remains on driving organic growth and strategic investments.
Advancing platform enhancements and unlocking greater value in the healthcare landscape.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.